Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin.
Zauli
Giorgio
G
Rimondi
Erika
E
Secchiero
Paola
P
D002454:Cell Differentiation; D002478:Cells, Cultured; D004347:Drug Interactions; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000166:cytology; D016173:Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000494:pharmacology; D010010:Osteoclasts / Q000187:drug effects* / Q000502:physiology; D053244:Osteoprotegerin / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D053245:RANK Ligand / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D012995:Solubility; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology*; D013997:Time Factors
D053244:Osteoprotegerin; D053245:RANK Ligand; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; D016173:Macrophage Colony-Stimulating Factor